Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder.

作者: Norio Yasui-Furukori , Shoko Tsuchimine , Taku Nakagami , Akira Fujii , Yasushi Sato

DOI: 10.1002/HUP.1192

关键词: Brain-derived neurotrophic factorNeurotrophic factorsInternal medicineIn patientBeta (finance)EndocrinologyPathophysiologyMajor depressive disorderAntidepressantParoxetineMedicine

摘要: Recent studies have implicated brain‐derived neurotrophic factor (BDNF) in the pathophysiology of depression and activities antidepressant drugs. Serum BDNF levels are lower depressed patients increase response to medications; however, no examined association between plasma concentrations drugs levels. We assessed paroxetine 45 with major who were being treated paroxetine. Plasma samples collected 10:00 h 12:00 at baseline after 1, 2 6 weeks treatment. The level concentration each sample measured via enzyme immunoassay high‐performance liquid chromatography, respectively. increased significantly men than women. Changes correlated drug (r = 0.309, p < 0.05) 0.329, but not 1 week 0.284, ns). Multiple regression analysis confirmed that this change was only (standardised beta 0.343, 0.375, 0.05). These results suggest treatment increases play an important role changes

参考文章(53)
Yanyan Shi, Jiayong You, Yonggui Yuan, Xiangrong Zhang, Hailin Li, Gang Hou, Plasma BDNF and tPA are associated with late-onset geriatric depression Psychiatry and Clinical Neurosciences. ,vol. 64, pp. 249- 254 ,(2010) , 10.1111/J.1440-1819.2010.02074.X
Armando Piccinni, Donatella Marazziti, Mario Catena, Luciano Domenici, Alessandro Del Debbio, Carolina Bianchi, Claudio Mannari, Claudia Martini, Eleonora Da Pozzo, Elisa Schiavi, Alessandra Mariotti, Isabella Roncaglia, Agnese Palla, Giorgio Consoli, Luca Giovannini, Gabriele Massimetti, Liliana Dell'Osso, Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments Journal of Affective Disorders. ,vol. 105, pp. 279- 283 ,(2008) , 10.1016/J.JAD.2007.05.005
Betina Elfving, Pia Høgh Plougmann, Gregers Wegener, Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: Pitfalls and solutions Journal of Neuroscience Methods. ,vol. 187, pp. 73- 77 ,(2010) , 10.1016/J.JNEUMETH.2009.12.017
Eiji Shimizu, Kenji Hashimoto, Naoe Okamura, Kaori Koike, Naoya Komatsu, Chikara Kumakiri, Michiko Nakazato, Hiroyuki Watanabe, Naoyuki Shinoda, Sin-ichi Okada, Masaomi Iyo, Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants Biological Psychiatry. ,vol. 54, pp. 70- 75 ,(2003) , 10.1016/S0006-3223(03)00181-1
Kiyofumi Yamada, Makoto Mizuno, Toshitaka Nabeshima, Role for brain-derived neurotrophic factor in learning and memory. Life Sciences. ,vol. 70, pp. 735- 744 ,(2002) , 10.1016/S0024-3205(01)01461-8
Armando Piccinni, Donatella Marazziti, Alessandro Del Debbio, Carolina Bianchi, Isabella Roncaglia, Claudio Mannari, Nicola Origlia, Mario Catena Dell'Osso, Gabriele Massimetti, Luciano Domenici, Liliana Dell'Osso, Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiology International. ,vol. 25, pp. 819- 826 ,(2008) , 10.1080/07420520802387773
Jeremy W. Pettit, Peter M. Lewinsohn, Thomas E. Joiner, Propagation of major depressive disorder: relationship between first episode symptoms and recurrence. Psychiatry Research-neuroimaging. ,vol. 141, pp. 271- 278 ,(2006) , 10.1016/J.PSYCHRES.2005.07.022
Félicien Karege, Michèle Schwald, Mbaye Cisse, Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets Neuroscience Letters. ,vol. 328, pp. 261- 264 ,(2002) , 10.1016/S0304-3940(02)00529-3